RNO 0.00% 4.0¢ rhinomed limited

Ann: Appendix 4C - quarterly, page-2

  1. 313 Posts.
    lightbulb Created with Sketch. 19
    Not a bad 4C in my mind. The reasons given for the tapering in growth rates were pretty valid and overall still a positive year.

    good news that they are still progressing the new product with Columbia care. seems a little bit underwhelming to announce it hidden in the 4C though.
 
watchlist Created with Sketch. Add RNO (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.